Correlation between the lymphocytes metabolic enzymes activity and the expression of some T cell surface markers in BAL fluid of sarcoid patients with different disease activity Source: Eur Respir J 2005; 26: Suppl. 49, 551s Year: 2005
The expression of antioxidants in small airways in COPD is increased, heterogeneous and correlates with local histopathological alterations Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Clinical parameters influencing fluid amount change and residual thickening in tuberculous pleurisy Source: Eur Respir J 2004; 24: Suppl. 48, 423s Year: 2004
Quantitative estimates of collagen accumulation and immune inflammatory response in relation to structural changes in COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
The activity of the inflammatory process and markers of an extracellular matrix destruction in pulmonary tuberculoma Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020
The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021
Analysis of oxymetazolines´ inflammation inhibiting and resolving properties in human neutrophils Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Relationship between macrophage inflammatory protein-3β(MIP-3β) levels and clinical course of sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002
Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Characteristics of the composition and level of cell-free DNA and nuclease activity in patients with cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019
Frequently used inflammation markers and their role in monitoring tuberculosis treatment Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008
BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011
Changes in the cellular composition of induced sputum in patients with asthma-COPD overlap Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006
Influence of antibiotics on neutrophil functional activity Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007